Medpace Holdings, Inc. Other Nonoperating Income (Expense)
Medpace Holdings, Inc. (MEDP) reported Other Nonoperating Income (Expense) of -$147.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-07-23
- Medpace Holdings, Inc. other nonoperating income (expense) for the quarter ending 2026-06-30 was -$147.00K.
- Medpace Holdings, Inc. other nonoperating income (expense) for the quarter ending 2026-03-31 was $971.00K.
- Medpace Holdings, Inc. other nonoperating income (expense) for the quarter ending 2025-12-31 was -$158.00K, a 125.44% decline year-over-year.
- Medpace Holdings, Inc. other nonoperating income (expense) for the quarter ending 2025-09-30 was -$489.00K.
- Medpace Holdings, Inc. other nonoperating income (expense) for fiscal 2025 was -$5.34M, a 231.61% decline from fiscal 2024.
- Medpace Holdings, Inc. other nonoperating income (expense) for fiscal 2024 was $4.06M.
- Medpace Holdings, Inc. other nonoperating income (expense) for fiscal 2023 was -$655.00K, a 109.27% decline from fiscal 2022.
- Medpace Holdings, Inc. other nonoperating income (expense) for fiscal 2022 was $7.07M, a 111.49% increase from fiscal 2021.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$147.00K 10-Q · filed 2026-07-23 | $824.00K 10-Q · filed 2026-07-23 | $666.00K derived: sum of 3 quarters · filed 2026-07-23 | $177.00K derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $971.00K 10-Q · filed 2026-04-23 | $813.00K derived: sum of 2 quarters · filed 2026-04-23 | $324.00K derived: sum of 3 quarters · filed 2026-04-23 | -$2.55M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | -$158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$647.00K derived: sum of 2 quarters · filed 2026-02-10 | -$3.52M derived: sum of 3 quarters · filed 2026-07-23 | -$5.34M 10-K · filed 2026-02-10 |
| 2025-09-30 | -$489.00K 10-Q · filed 2025-10-23 | -$3.36M derived: sum of 2 quarters · filed 2026-07-23 | -$5.18M 10-Q · filed 2025-10-23 | -$4.56M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | -$2.88M 10-Q · filed 2026-07-23 | -$4.69M 10-Q · filed 2026-07-23 | -$4.07M derived: sum of 3 quarters · filed 2026-07-23 | -$5.09M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | -$1.82M 10-Q · filed 2026-04-23 | -$1.20M derived: sum of 2 quarters · filed 2026-04-23 | -$2.22M derived: sum of 3 quarters · filed 2026-04-23 | -$2.35M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | $621.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$404.00K derived: sum of 2 quarters · filed 2026-02-10 | -$537.00K derived: sum of 3 quarters · filed 2026-02-10 | $4.06M 10-K · filed 2026-02-10 |
| 2024-09-30 | -$1.02M 10-Q · filed 2025-10-23 | -$1.16M derived: sum of 2 quarters · filed 2025-10-23 | $3.44M 10-Q · filed 2025-10-23 | $4.98M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | -$133.00K 10-Q · filed 2025-07-22 | $4.46M 10-Q · filed 2025-07-22 | $6.00M derived: sum of 3 quarters · filed 2026-02-10 | $4.40M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $4.59M 10-Q · filed 2025-04-22 | $6.14M derived: sum of 2 quarters · filed 2026-02-10 | $4.53M derived: sum of 3 quarters · filed 2026-02-10 | $3.25M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$59.00K derived: sum of 2 quarters · filed 2026-02-10 | -$1.34M derived: sum of 3 quarters · filed 2026-02-10 | -$655.00K 10-K · filed 2026-02-10 |
| 2023-09-30 | -$1.60M 10-Q · filed 2024-10-22 | -$2.88M derived: sum of 2 quarters · filed 2024-10-22 | -$2.20M 10-Q · filed 2024-10-22 | -$4.16M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | -$1.28M 10-Q · filed 2024-07-23 | -$596.00K 10-Q · filed 2024-07-23 | -$2.56M derived: sum of 3 quarters · filed 2025-02-11 | $3.09M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | $687.00K 10-Q · filed 2024-04-23 | -$1.27M derived: sum of 2 quarters · filed 2025-02-11 | $4.38M derived: sum of 3 quarters · filed 2025-02-11 | $6.69M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | -$1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $3.69M derived: sum of 2 quarters · filed 2025-02-11 | $6.00M derived: sum of 3 quarters · filed 2025-02-11 | $7.07M 10-K · filed 2025-02-11 |
| 2022-09-30 | $5.65M 10-Q · filed 2023-10-24 | $7.96M derived: sum of 2 quarters · filed 2023-10-24 | $9.03M 10-Q · filed 2023-10-24 | $10.12M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $2.31M 10-Q · filed 2023-07-25 | $3.38M 10-Q · filed 2023-07-25 | $4.47M derived: sum of 3 quarters · filed 2024-02-13 | $5.53M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $1.07M 10-Q · filed 2023-04-25 | $2.16M derived: sum of 2 quarters · filed 2024-02-13 | $3.22M derived: sum of 3 quarters · filed 2024-02-13 | $3.48M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $2.15M derived: sum of 2 quarters · filed 2024-02-13 | $2.42M derived: sum of 3 quarters · filed 2024-02-13 | $3.34M 10-K · filed 2024-02-13 |
| 2021-09-30 | $1.06M 10-Q · filed 2022-10-25 | $1.33M derived: sum of 2 quarters · filed 2022-10-25 | $2.25M 10-Q · filed 2022-10-25 | $2.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $265.00K 10-Q · filed 2022-07-26 | $1.19M 10-Q · filed 2022-07-26 | $932.00K derived: sum of 3 quarters · filed 2023-02-14 | $1.52M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $924.00K 10-Q · filed 2022-04-26 | $667.00K derived: sum of 2 quarters · filed 2023-02-14 | $1.25M derived: sum of 3 quarters · filed 2023-02-14 | $1.49M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | -$257.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $327.00K derived: sum of 2 quarters · filed 2023-02-14 | $566.00K derived: sum of 3 quarters · filed 2023-02-14 | $1.18M 10-K · filed 2023-02-14 |
| 2020-09-30 | $584.00K 10-Q · filed 2021-10-26 | $823.00K derived: sum of 2 quarters · filed 2021-10-26 | $1.44M 10-Q · filed 2021-10-26 | $1.15M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $239.00K 10-Q · filed 2021-07-27 | $856.00K 10-Q · filed 2021-07-27 | $567.00K derived: sum of 3 quarters · filed 2022-02-15 | $294.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $617.00K 10-Q · filed 2021-04-27 | $328.00K derived: sum of 2 quarters · filed 2022-02-15 | $55.00K derived: sum of 3 quarters · filed 2022-02-15 | $36.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | -$289.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | -$562.00K derived: sum of 2 quarters · filed 2022-02-15 | -$581.00K derived: sum of 3 quarters · filed 2022-02-15 | -$863.00K 10-K · filed 2022-02-15 |
| 2019-09-30 | -$273.00K 10-Q · filed 2020-10-27 | -$292.00K derived: sum of 2 quarters · filed 2020-10-27 | -$574.00K 10-Q · filed 2020-10-27 | -$321.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | -$19.00K 10-Q · filed 2020-07-28 | -$301.00K 10-Q · filed 2020-07-28 | -$48.00K derived: sum of 3 quarters · filed 2021-02-16 | $434.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | -$282.00K 10-Q · filed 2020-04-29 | -$29.00K derived: sum of 2 quarters · filed 2021-02-16 | $453.00K derived: sum of 3 quarters · filed 2021-02-16 | $931.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $253.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $735.00K derived: sum of 2 quarters · filed 2021-02-16 | $1.21M derived: sum of 3 quarters · filed 2021-02-16 | $1.06M 10-K · filed 2021-02-16 |
| 2018-09-30 | $482.00K 10-Q · filed 2019-10-29 | $960.00K derived: sum of 2 quarters · filed 2019-10-29 | $807.00K 10-Q · filed 2019-10-29 | $1.09M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $478.00K 10-Q · filed 2019-07-30 | $325.00K 10-Q · filed 2019-07-30 | $613.00K derived: sum of 3 quarters · filed 2020-02-25 | $468.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | -$153.00K 10-Q · filed 2019-04-30 | $135.00K derived: sum of 2 quarters · filed 2020-02-25 | -$10.00K derived: sum of 3 quarters · filed 2020-02-25 | -$135.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $288.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $143.00K derived: sum of 2 quarters · filed 2020-02-25 | $18.00K derived: sum of 3 quarters · filed 2020-02-25 | -$354.00K 10-K · filed 2020-02-25 |
| 2017-09-30 | -$145.00K 10-Q · filed 2018-10-30 | -$270.00K derived: sum of 2 quarters · filed 2018-10-30 | -$642.00K 10-Q · filed 2018-10-30 | $254.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | -$125.00K 10-Q · filed 2018-07-31 | -$497.00K 10-Q · filed 2018-07-31 | $399.00K derived: sum of 3 quarters · filed 2019-02-26 | $21.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | -$372.00K 10-Q · filed 2018-05-01 | $524.00K derived: sum of 2 quarters · filed 2019-02-26 | $146.00K derived: sum of 3 quarters · filed 2019-02-26 | $140.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $896.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $518.00K derived: sum of 2 quarters · filed 2019-02-26 | $512.00K derived: sum of 3 quarters · filed 2019-02-26 | -$423.00K 10-K · filed 2019-02-26 |
| 2016-09-30 | -$378.00K 10-Q · filed 2017-10-31 | -$384.00K derived: sum of 2 quarters · filed 2017-10-31 | -$1.32M 10-Q · filed 2017-10-31 | -$1.52M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$6.00K 10-Q · filed 2017-08-01 | -$941.00K 10-Q · filed 2017-08-01 | -$1.15M derived: sum of 3 quarters · filed 2018-02-27 | -$1.10M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | -$935.00K 10-Q · filed 2017-05-02 | -$1.14M derived: sum of 2 quarters · filed 2018-02-27 | -$1.09M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2015-12-31 | -$205.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$155.00K derived: sum of 2 quarters · filed 2018-02-27 | -$1.13M 10-K · filed 2018-02-27 | |
| 2015-09-30 | $50.00K 10-Q · filed 2016-11-03 | -$928.00K 10-Q · filed 2016-11-03 | ||
| 2014-12-31 | -$301.00K 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |